A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05005728

Study #:
STUDY00148969

Start Date:
Nov 15, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05005728

View Complete Trial Details & Eligibility at ClinicalTrials.gov